Page 13 - Chinese (SSE) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Jul 18, 2024

Discover Chinese Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the SSE and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

297 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

688298

Zhejiang Orient Gene BiotechLtd
CN¥25.62-0.4%-32.2%CN¥5.2bn/aPS8.2xn/a0%

2019

Yifan Pharmaceutical
CN¥12.11-1.0%-12.6%CN¥14.7bCN¥19.00PS3.3xE67.7%0%

2581

Shandong Sinobioway Biomedicine
CN¥9.190.3%-48.4%CN¥6.1bn/aPS13.8xn/a0%

688114

MGI Tech
CN¥45.401.6%-51.3%CN¥18.7bCN¥83.09PS6.6xE125.3%0%

2793

Luoxin Pharmaceuticals Group Stock
CN¥3.95-3.4%-26.7%CN¥4.3bn/aPS1.8xn/a0%

2750

Kunming Longjin Pharmaceutical
CN¥1.9625.6%-78.3%CN¥785.0mn/aPS8.6xn/a0%

688670

Jiangsu Gdk Biological Technology
CN¥11.08-6.0%-61.2%CN¥1.4bn/aPS40.9xE102.4%0%

603520

Zhejiang Starry PharmaceuticalLtd
CN¥9.29-3.1%-42.7%CN¥4.1bCN¥17.54PE86.8xE63.4%0%

813

Dezhan Healthcare
CN¥2.400.4%-17.8%CN¥5.2bn/aPE80.4xn/a0%
Page 13 of 13
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.